Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

A neurologist grapples with aducanumab

Anonymous
Conditions
January 26, 2022
Share
Tweet
Share

I have been following the controversy surrounding the approval of the new Alzheimer’s drug aducanumab with great interest.  Until a year and a half ago, I worked as a neurologist in an adult general neurology clinic.   Many of my patients had dementia.  While I thoroughly enjoyed seeing these patients and their family members, I often felt helpless when treating them.  When I left clinical practice to explore a non-clinical career in the pharmaceutical industry, I envisioned helping patients with neurological conditions by bringing much-needed drugs to market.  Drugs like aducanumab.

Aducanumab is the first disease-modifying drug approved for Alzheimer’s disease (AD) and the first AD medication to be approved in nearly two decades.  This should be exciting.  Instead, I find aducanumab’s approval both confusing and worrisome.  Simply stated, the drug has significant side effects, and it is unclear whether it has meaningful clinical benefit.  Despite the eleven-person neurological advisory board almost unanimously voting against approval, the FDA approved the drug this past summer via the accelerated approval process.  Subsequently, three of the neurologists on the advisory board quit, and there have been multiple editorials questioning the integrity of the FDA and its relationship with the pharmaceutical industry.

Within the pharmaceutical world, the approval of aducanumab is exciting.  It may pave the way for the approval of other AD drugs and drugs for other indications via the accelerated approval process.  At heart though, I am still a clinician and cannot help but imagine what I would do if I were still in practice.  Until there is more information about outcomes, I would not be inclined to prescribe it.  However, I suspect there would be great pressure from desperate patients and their families, and likely from the hospital system.

Closer to home, I contemplate aducanumab as it concerns my father-in-law, a retired cardiologist with mild AD.  Both my in-laws are declining.  They seem to be in the emergency department weekly, if not more often, and we are in the process of increasing their supervision via hiring a concierge physician and engaging a social worker to help them.  Recently, my father-in-law had multiple side effects from sequential trials of two acetylcholinesterase inhibitors discontinued due to intolerance.  I worry how he would fare if he had side effects from aducanumab, particularly symptomatic amyloid-related imaging abnormalities (ARIA), the anxiety this would cause, and the multiple MRIs and clinic follow-ups.

Last summer, my in-laws asked me about this pipeline drug they had heard about.  At that time, I told them the approval of aducanumab was unlikely and I did not revisit this with them once the surprise approval occurred.  More recently, I felt shame over keeping this information from them.  In my attempt to protect my in-laws, I deprived them of their autonomy.  At Thanksgiving, I came clean and told them about it, but fortunately, at least for now, my father-in-law’s neurologist does not plan on prescribing this drug.  I admit I am relieved.  I do not have to navigate the politics of aducanumab with my in-laws or with patients.  My former colleagues are not so lucky.

The author is an anonymous physician.

Image credit: Shutterstock.com

Prev

Setting boundaries and the power of saying no

January 26, 2022 Kevin 0
…
Next

Men's health is a catastrophe. Here's how we can help. [PODCAST]

January 26, 2022 Kevin 2
…

Tagged as: Neurology

Post navigation

< Previous Post
Setting boundaries and the power of saying no
Next Post >
Men's health is a catastrophe. Here's how we can help. [PODCAST]

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Anonymous

  • Why young doctors in South Korea feel broken before they even begin

    Anonymous
  • Do Jewish students face rising bias in holistic admissions?

    Anonymous
  • Medical students in Korea face expulsion for speaking out

    Anonymous

Related Posts

  • Does the FDA approval of aducanumab mark the return of science-based medicine?

    Robert Trent
  • Can the Maternal CARE Act fail moms? 

    Sonal Patel, MD
  • Our patients matter, but at what cost to our families? 

    James A. Quinn, PA-C
  • For students with test stress, medical schools leave a void  

    Steve Blatt, MD
  • Opening schools? The devil is in the details. 

    Raghav Gupta, MD
  • Qualifying conditions for medical marijuana

    Patricia Frye

More in Conditions

  • 5 cancer myths that could delay your diagnosis or treatment

    Joseph Alvarnas, MD
  • When bleeding disorders meet IVF: Navigating von Willebrand disease in fertility treatment

    Oluyemisi Famuyiwa, MD
  • What one diagnosis can change: the movement to make dining safer

    Lianne Mandelbaum, PT
  • How kindness in disguise is holding women back in academic medicine

    Sylk Sotto, EdD, MPS, MBA
  • Measles is back: Why vaccination is more vital than ever

    American College of Physicians
  • Hope is the lifeline: a deeper look into transplant care

    Judith Eguzoikpe, MD, MPH
  • Most Popular

  • Past Week

    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • The hidden cost of becoming a doctor: a South Asian perspective

      Momeina Aslam | Education
    • Physician patriots: the forgotten founders who lit the torch of liberty

      Muhamad Aly Rifai, MD | Physician
    • If I had to choose: Choosing the patient over the protocol

      Patrick Hudson, MD | Physician
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Recent Posts

    • If I had to choose: Choosing the patient over the protocol

      Patrick Hudson, MD | Physician
    • How a TV drama exposed the hidden grief of doctors

      Lauren Weintraub, MD | Physician
    • Why adults need to rediscover the power of play

      Anthony Fleg, MD | Physician
    • How collaboration across medical disciplines and patient advocacy cured a rare disease [PODCAST]

      The Podcast by KevinMD | Podcast
    • 5 cancer myths that could delay your diagnosis or treatment

      Joseph Alvarnas, MD | Conditions
    • When bleeding disorders meet IVF: Navigating von Willebrand disease in fertility treatment

      Oluyemisi Famuyiwa, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • The hidden cost of becoming a doctor: a South Asian perspective

      Momeina Aslam | Education
    • Physician patriots: the forgotten founders who lit the torch of liberty

      Muhamad Aly Rifai, MD | Physician
    • If I had to choose: Choosing the patient over the protocol

      Patrick Hudson, MD | Physician
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Recent Posts

    • If I had to choose: Choosing the patient over the protocol

      Patrick Hudson, MD | Physician
    • How a TV drama exposed the hidden grief of doctors

      Lauren Weintraub, MD | Physician
    • Why adults need to rediscover the power of play

      Anthony Fleg, MD | Physician
    • How collaboration across medical disciplines and patient advocacy cured a rare disease [PODCAST]

      The Podcast by KevinMD | Podcast
    • 5 cancer myths that could delay your diagnosis or treatment

      Joseph Alvarnas, MD | Conditions
    • When bleeding disorders meet IVF: Navigating von Willebrand disease in fertility treatment

      Oluyemisi Famuyiwa, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...